This website uses cookies

The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.

No full text
Poster (Scientific congresses and symposiums)
Exploring Venomics and Antivenomics in the ADDovenom Project: Advancing Next-Generation Antivenoms based on Virus-Like Particles
Redureau, Damien
2024IST 2024
 

Files


Full Text
No document available.

Send to



Details



Abstract :
[en] The advancement of snakebite therapeutics is imperative due to the substantial morbidity and mortality associated with envenomation. Treatments based on animal-derived antivenoms face limitations in efficacy, safety and cost-effectiveness. To overcome these challenges, the ADDovenom project aims to introduce a groundbreaking snakebite therapy utilizing thermostable protein-based ADDomer nanoparticles. These nanoparticles, derived from the adenovirus penton base protein, provide 60 high avidity binding sites for venom toxins, potentially revolutionizing antivenom development. Through cutting-edge protein engineering, expression technology, and mass spectrometry, alongside venom neutralization assays, the project delineates methodologies to develop next-generation antivenoms with unparalleled efficacy, safety, and affordability.
Disciplines :
Chemistry
Author, co-author :
Redureau, Damien ;  Université de Liège - ULiège > Molecular Systems (MolSys)
Language :
English
Title :
Exploring Venomics and Antivenomics in the ADDovenom Project: Advancing Next-Generation Antivenoms based on Virus-Like Particles
Publication date :
20 May 2024
Event name :
IST 2024
Event organizer :
IST
Event place :
Singapour, Singapore
Event date :
20/05/2024 - 25/05/2024
Audience :
International
Available on ORBi :
since 28 August 2024

Statistics


Number of views
27 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Sorry the service is unavailable at the moment. Please try again later.
Contact ORBi